CD36 Deficiency in Platelet Donors and Clinical Transfusion Practice: A Comprehensive Critical Review of Key Molecular, Epidemiological, and Translational Studies.
文献摘要
CD36 deficiency demonstrates higher frequency among East Asian populations and is closely associated with alloimmunization risk. This critical review systematically evaluates 6 landmark studies that have advanced understanding of CD36 deficiency, including its epidemiological characteristics in Chinese and Japanese populations, molecular mechanisms involving genomic-complementary DNA (cDNA) discordance, alternative splicing, regulatory haplotypes, messenger RNA (mRNA) expression and soluble CD36 as a potential biomarker, as well as clinical correlations with transfusion-related adverse events. Scientific strengths, methodological limitations and generalizability of each study were comprehensively assessed. The results demonstrate distinct ethnic genetic differentiation of CD36 deficiency caused by recurrent variants, noncoding regulatory variations and alternative splicing, with clear genotype-transcript divergence distinguishing type I and type II deficiency. Major strengths include large cohorts, rigorous flow cytometric phenotyping and high-resolution sequencing; limitations include regional bias, limited prospective follow-up and incomplete mechanisms of platelet-specific CD36 silencing. Critical gaps remain in lineage-specific regulation, standardized screening and multiethnic genetics. Future research should focus on multi-center prospective cohorts, long-read sequencing, functional validation and clinical guidelines to reduce transfusion complications. This review offers translational insights for both basic research and clinical transfusion practice.